Hsbc Holdings PLC Buys 2,215,832 Shares of Select Medical Holdings Corporation $SEM

Hsbc Holdings PLC increased its stake in Select Medical Holdings Corporation (NYSE:SEM) by 7,554.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,245,163 shares of the health services provider’s stock after purchasing an additional 2,215,832 shares during the period. Hsbc Holdings PLC owned 1.81% of Select Medical worth $36,596,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Price T Rowe Associates Inc. MD lifted its stake in shares of Select Medical by 4.3% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 16,606,269 shares of the health services provider’s stock valued at $246,604,000 after acquiring an additional 684,695 shares during the period. Dimensional Fund Advisors LP boosted its stake in shares of Select Medical by 2.6% in the 4th quarter. Dimensional Fund Advisors LP now owns 5,333,595 shares of the health services provider’s stock valued at $79,205,000 after purchasing an additional 136,252 shares during the last quarter. State Street Corp grew its position in shares of Select Medical by 1.3% during the 2nd quarter. State Street Corp now owns 4,253,793 shares of the health services provider’s stock worth $64,573,000 after buying an additional 55,686 shares during the period. Western Standard LLC lifted its holdings in Select Medical by 95.6% in the fourth quarter. Western Standard LLC now owns 2,064,021 shares of the health services provider’s stock valued at $30,651,000 after buying an additional 1,008,664 shares during the period. Finally, 8 Knots Management LLC bought a new position in Select Medical in the second quarter valued at approximately $26,568,000. 89.48% of the stock is owned by institutional investors and hedge funds.

Select Medical Stock Performance

SEM stock opened at $16.51 on Tuesday. Select Medical Holdings Corporation has a 1-year low of $11.65 and a 1-year high of $16.99. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.88. The firm has a market cap of $2.05 billion, a PE ratio of 15.58, a P/E/G ratio of 0.95 and a beta of 1.01. The business’s 50-day moving average price is $16.53 and its two-hundred day moving average price is $16.10.

Select Medical (NYSE:SEM) last released its quarterly earnings results on Thursday, April 30th. The health services provider reported $0.36 EPS for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.07). Select Medical had a return on equity of 6.62% and a net margin of 2.42%.The business had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.41 billion. During the same period in the prior year, the business earned $0.44 EPS. The company’s revenue for the quarter was up 5.0% compared to the same quarter last year. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. As a group, research analysts forecast that Select Medical Holdings Corporation will post 1.26 earnings per share for the current year.

Select Medical Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, May 28th. Shareholders of record on Thursday, May 14th were paid a $0.0625 dividend. The ex-dividend date of this dividend was Thursday, May 14th. This represents a $0.25 annualized dividend and a dividend yield of 1.5%. Select Medical’s dividend payout ratio (DPR) is currently 23.58%.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the company. Weiss Ratings raised Select Medical from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, June 4th. Mizuho reissued a “neutral” rating and issued a $16.50 target price (down from $17.00) on shares of Select Medical in a research note on Tuesday, May 12th. Finally, Zacks Research upgraded Select Medical from a “strong sell” rating to a “hold” rating in a research report on Monday, May 4th. One analyst has rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, Select Medical currently has an average rating of “Hold” and an average price target of $15.50.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.